Literature DB >> 11011501

Ericksonian approaches to hypnosis and therapy: where are we now?

W J Matthews1.   

Abstract

Ericksonian approaches to psychotherapy and hypnosis have had a significant impact on many clinical practitioners over the last two decades. This article reviews the current empirical research with regard to the efficacy of these treatment approaches as well as for the key Ericksonian assumptions of: (a) belief in an altered state of consciousness and the existence of specific markers indicating an altered state; (b) the superiority of indirect suggestion over direct suggestion; and (c) client hypnotizability is a function of the hypnotist's skill. The current literature provides empirical support neither for efficacy nor for these key assumptions. The article concludes with a discussion of the need for empirically based research to test the efficacy of Ericksonian therapy and its core components, lest this approach become isolated from the scientific hypnosis and therapy communities.

Mesh:

Year:  2000        PMID: 11011501     DOI: 10.1080/00207140008410370

Source DB:  PubMed          Journal:  Int J Clin Exp Hypn        ISSN: 0020-7144


  3 in total

1.  The Altered States of Consciousness in Transpersonal Approach Psychotherapy: Systematic Review and Guidelines for Research and Clinical Practice.

Authors:  Milena Nardini-Bubols; Daniele Silva da Silva; Andrea Dos Santos-Silva; Olivia Kacey Stagnaro; Tatiana Quarti Irigaray; Letícia Oliveira Alminhana
Journal:  J Relig Health       Date:  2019-12

2.  Talking to the senses: modulation of tactile extinction through hypnotic suggestion.

Authors:  Angelo Maravita; Mario Cigada; Lucio Posteraro
Journal:  Front Hum Neurosci       Date:  2012-07-17       Impact factor: 3.169

3.  Virtual Therapeutic Garden: A Promising Method Supporting the Treatment of Depressive Symptoms in Late-Life: A Randomized Pilot Study.

Authors:  Joanna Szczepańska-Gieracha; Błażej Cieślik; Anna Serweta; Krzysztof Klajs
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.